Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 7,493 calls trading, 2x expected, and implied vol increasing almost 4 points to 94.34%. Jan-25 6 calls and Jun-25 7 calls are the ...

I am working on a project for my assembly language programming class and the prof has us writing a program to calculate fibonacci numbers but we need to make only 1 recursive call. Here is my ...

Earnings call Recursion Pharmaceuticals reported a strategic pipeline overhaul, discontinuing lower-priority programs and focusing on five high-potential clinical and preclinical assets. The company ...

SALT LAKE CITY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide ...

Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I am really excited to welcome you to our first ever Learnings Call here at Recursion. So what is a learnings call and why are we ...

Earnings call Recursion ended Q2 2025 with $533M in cash and reiterated its expected cash runway through Q4 2027. The company advanced multiple internal oncology and rare disease programs, hit its ...

Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I'm so delighted you've joined us today for our Q1 2024 Earnings Call -- L(earnings) Call, as we call it. And I want to run ...